Fulgent Genetics Inc. Watch

from 10-K 5 pages Description of Fulgent Genetics, Inc.’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 Description of Capital Stock

from 10-K 5 pages Description of Fulgent Genetics, Inc.’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 Description of Capital Stock

from S-3 43 pages Fulgent Genetics, Inc. Issuer and [ ] Trustee Indenture Dated as of [ ] Subordinated Debt Securities

from S-3 42 pages Fulgent Genetics, Inc. Issuer and [ ] Trustee Indenture Dated as of [ ] Senior Debt Securities

from 10-K 4 pages Description of Fulgent Genetics, Inc.’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 Description of Capital Stock

from S-3 42 pages Fulgent Genetics, Inc. Issuer and [ ] Trustee Indenture Dated as of [ ] Subordinated Debt Securities

from S-3 42 pages Fulgent Genetics, Inc. Issuer and [ ] Trustee Indenture Dated as of [ ] Senior Debt Securities

from S-1/A 2 pages Zq|cert#|coy|cls|rgstry|acct#|transtype|run#|trans# Fulgent Po Box 43004, Providence, Ri 02940-3004 Mr a Sample Designation (If Any) Add 1 Add 2 Add 3 Add 4 Cusip Xxxxxx XX X Holder Id Xxxxxxxxx Insurance Value 1,000,000.00 Number of Shares 123456 Dtc 12345678 123456789012345 Certificate Numbers Num/No. Denom. Total 1234567890/1234567890 1 1 1 1234567890/1234567890 2 2 2 1234567890/1234567890 3 3 3 1234567890/1234567890 4 4 4 1234567890/1234567890 5 5 5 1234567890/1234567890 6 6 6 Total Transaction 7 Common Stock Common Stock Par Value $.0001 This Certificate Is Transferable in Canton, Ma, Jersey City, Nj and College Station, Tx Certificate Number Zq00000000 Fulgent Fulgent Gentics, Inc. Incorporated Under the Laws of the State of Delaware Shares * * 000000 ****************** * * * 000000 ***************** **** 000000 **************** ***** 000000 *************** ****** 000000 **************

from S-1 19 pages Fulgent Therapeutics LLC Investor’s Rights Agreement Dated as of May 17, 2016

from DRS 19 pages Fulgent Therapeutics LLC Investor’s Rights Agreement Dated as of May 17, 2016